Clinical Trials Database

Results (94 trials):	Page: 1 2 3 4
Title	Phase	Status	Conditions
A Broad Multi-Histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) In Advanced Colorectal, Non-Small Cell Lung, Head and Neck, Hepatocelluar and Renal Cell Carcinomas and Pheochromocytoma and Thyroid Tumors	II	Enrolling	Pheochromocytoma
A Broad Multi-Histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) In Advanced Colorectal, Non-Small Cell Lung, Head and Neck, Hepatocelluar and Renal Cell Carcinomas and Pheochromocytoma and Thyroid Tumors	II	Enrolling	Pheochromocytoma
A Collection of Clinical and Epidemiologic Data Combined With Tissue and Blood From Patients With a Diagnosis of Neuroendocrine Tumors		Enrolling	Carcinoid Tumor, Neuroendocrine Tumor
A Multiple Ascending Dose Study of the mTOR Inhibitor (RAD001) in Combination With R1507 in Patients With Advanced Solid Tumors	I	Not Recruiting	Neuroendocrine Tumor, Pancreatic Neuroendocrine Tumor
A Phase 1b/2 Trial of AMG 479 or AMG 102 in Combination With Platinum-based Chemotherapy as First-Line Treatment for Extensive Stage Small Cell Lung Cancer	I/II	Enrolling	Pulmonary Carcinoid
A Phase II Study of Pertuzumab and Erlotinib for Metastatic or Unresectable Neuroendocrine Tumors	II	Enrolling	Carcinoid Tumor, Neuroendocrine Tumor
A Study Evaluating Ultratrace Iobenguane I 131(MIBG)in Patients With Malignant Pheochromocytoma/Paraganglioma	II	Enrolling	Pheochromocytoma
AMG 479 in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors	II	Enrolling	Carcinoid Tumor, Neuroendocrine Tumor, Pancreatic Neuroendocrine Tumor
AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors	II	Not Recruiting	Carcinoid Tumor, Neuroendocrine Tumor
AMG 706 in Treating Patients With Low-Grade Neuroendocrine Tumors	II	Enrolling	Neuroendocrine Tumor
An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome	III	Enrolling	Carcinoid Tumor
An Investigation of Small Intestinal Carcinoid Carcinoma in Families	II	Enrolling	Carcinoid Tumor
Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine Carcinoma	II	Not Recruiting	Neuroendocrine Tumor
BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors	I	Enrolling	Neuroendocrine Tumor
Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors	II	Not Recruiting	Neuroendocrine Tumor
CBT-1 and Paclitaxel in Treating Patients With Refractory, Recurrent, or Advanced Metastatic Solid Tumors	I	Not Recruiting	Neuroendocrine Tumor
CCI-779 in Treating Patients With Progressive Metastatic Neuroendocrine Tumors	II	Not Recruiting	Carcinoid Tumor, Neuroendocrine Tumor
Cisplatin and Etoposide Phosphate With or Without GDC-0449 or Cixutumumab in Treating Patients With Extensive-Stage Small Cell Lung Cancer	II	Enrolling	Pulmonary Carcinoid
Clinical and Translational Study of MK-0646 in Patients With Metastatic Neuroendocrine Tumors (NET)	II	Enrolling	Neuroendocrine Tumor
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders		Enrolling	Pancreatic Neuroendocrine Tumor
Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors	I, II	Not Recruiting	Carcinoid Tumor, Neuroendocrine Tumor
Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer	II	Not Recruiting	Carcinoid Tumor, Neuroendocrine Tumor
Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer	II	Not Recruiting	Carcinoid Tumor, Pancreatic Neuroendocrine Tumor
Combination of Bevacizumab, Pertuzumab, and Sandostatin for Adv. Neuroendocrine Cancers	II	Enrolling	Neuroendocrine Tumor
Combination Targeted Radiotherapy in Neuroendocrine Tumors		Not Recruiting	Neuroendocrine Tumor

To receive the most up-to-date information on clinical trials (such as new clinical trials and recently peer-reviewed publications) sign up here:

For Email Marketing you can trust

CFCF Profile

CFCF FAQ

Is it possible to cure carcinoid?

How long will it take to
cure carcinoid?

How much money will be needed to cure carcinoid?

Will achieving our mission benefit all carcinoid patients?

One Kendall Square | PMB 180 | Cambridge, MA 02139 | (857) 222-5492 |

Warning: Unknown: Your script possibly relies on a session side-effect which existed until PHP 4.2.3. Please be advised that the session extension does not consider global variables as a source of data, unless register_globals is enabled. You can disable this functionality and this warning by setting session.bug_compat_42 or session.bug_compat_warn to off, respectively. in Unknown on line 0

Clinical Trials Finder

CFCF Profile

CFCF Doctor Database

CFCF FAQ